中石化儀征化纖加速熔噴布增產
據《新華社》報道,中石化儀征化纖第5條年產500噸熔噴布生產線一次投產成功。有企業負責人表示,企業加快投產增產,並將按照統籌定向供應,不對其他企業和個人銷售。
新冠肺炎疫情期間,中石化在北京燕山石化和江蘇儀征化纖兩家企業布局相關生產線,儀征化纖承擔其中12條熔噴布生產線的建設任務。
自3月29日首條生產線投產以來,儀征化纖的熔噴布日產量達6噸,已累計生產優質熔噴布65噸,助力增產醫用口罩6,500萬個。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.